Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C

Sherief Abd-Elsalam1,200 enrolled

Overview

Alpha-fetoprotein Levels on the Response to direct Antiviral Therapy in Patients with Chronic Hepatitis C

Impact of Serum Alpha-fetoprotein Levels on the Response to direct Antiviral Therapy in Egyptian Patients with Chronic Hepatitis C

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

1,200

Conditions

Hepatitis C

Interventions

Sofosbuvir and Ledipasvir or sofosbuvir and daklatasuvirDRUG

Response to DAAD's and developing HCC

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * HCV patients who will undergo treatment by direct acting antiviral agents. Exclusion Criteria: * Patients with decompensated liver disease

Locations (1)

Sherief Abd-Elsalam

Tanta, Egypt

RECRUITING

Outcomes

Primary Outcomes

Number of patients with sustained virologic response

The total number of patients with SVR in each group

Time frame: 6 months

Central Contacts

Sherief Abd-Elsalam, md

CONTACT

00201095159522 sheriefabdelsalam@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.